Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02306122 · ClinicalTrials.gov registry record · NA
Pharmacy Home Adherence Reporting and Monitoring Outcomes Study
A NA study, sponsored by Brown University.
- Completed
- Registry status
- NA
- Development phase
- 2,697
- Enrollment target
NCT02306122: Completed NA study, sponsored by Brown University.
NCT02306122 is a NA study that has completed, run by Brown University. The registered enrollment target is 2,697 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02306122, a NA study, has completed, sponsored by Brown University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,697 participants
- Enrollment target
Study Summary
This study is a pilot test of an intervention that delivers timely diagnostic information about medication nonadherence to doctors, and then offers the services of clinical pharmacists to treat these nonadherence problems. Participating doctors will be notified when a patient is 10 days late refilling a medication for diabetes, hypertension, or hypercholesterolemia. In one randomization arm the pharmacist will contact the patient as the default option (with no action required by the doctor), and in the other the pharmacist will contact the patient only if the doctor actively chooses that the pharmacist take action. Patients of participating doctors will be randomized to 1) one of these two pharmacist options, 2) an information only control arm in which the doctor gets adherence information but does not have access to a pharmacist for that patient, and 3) a no information control arm. The investigators' central hypothesis is that the pharmacist will be consulted more often when intervention by the pharmacist is the default outcome and that the default pharmacist intervention will be the most beneficial for adherence outcomes.
Primary Outcome
Patients who were more than 10 days late refilling a chronic medication prescription were in the analytic sample frame and were targeted for intervention according to how they were randomized. This outcome is the rate at which these patients have filled a prescription by 30 days. Outcome is 1 if the patient fills the prescription by 30 days (considered resolution of nonadherence); otherwise it is 0. Outcome measures reported are the means of the per-person proportions of nonadherence (NAE) event
Interventions
- BEHAVIORAL Pharmacist calls patient unless physician cancels call
- BEHAVIORAL Patient nonadherence information sent to physician
- BEHAVIORAL Pharmacist calls patient if physician requests call
- BEHAVIORAL Doctor receives information and may be allowed certain actions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,697 participants |
| Start Date | 2011-03 |
| Est. Completion | 2014-02 |
| Phase | NA |
What the finished NCT02306122 record still lists
NCT02306122 is an interventional study that assigns participants to a tested intervention. Its 2,697 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% higher).
The record links to 0 conditions, and to 4 interventions - of which Pharmacist calls patient unless physician cancels call is the first listed.
NCT02306122 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02306122 about?
NCT02306122 is a clinical study titled "Pharmacy Home Adherence Reporting and Monitoring Outcomes Study". This study is a pilot test of an intervention that delivers timely diagnostic information about medication nonadherence to doctors, and then offers the services of clinical pharmacists to treat these nonadherence problems. Participating doctors will be notified when a patient is 10 days late refilli...
What is the current status of trial NCT02306122?
This trial is currently completed. It is a NA study. The enrollment target is 2,697 participants. The study started on 2011-03. Estimated completion is 2014-02.
What interventions are being tested in trial NCT02306122?
The interventions under investigation include: Pharmacist calls patient unless physician cancels call (BEHAVIORAL), Patient nonadherence information sent to physician (BEHAVIORAL), Pharmacist calls patient if physician requests call (BEHAVIORAL), Doctor receives information and may be allowed certain actions (BEHAVIORAL).
Who is sponsoring clinical trial NCT02306122?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02306122's enrollment target sits among peer trials
2,697 44th of 2000 higher than 1,957 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04073420 · 2,700 participants
Medtronic Cardiac Surgery PMCF Registry
- NCT05125939 · 2,700 participants
Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study
- NCT05586776 · 2,700 participants · Phase 4
Decolonization to Reduce After-Surgery Events of Surgical Site Infection
- NCT06052267 · 2,700 participants · Phase 3
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia